Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 14, 2015
Grant Date -
May 8, 2014
app pub date -
Apr 17, 2012
filing date -
Apr 19, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention relates to novel substituted phenoxyethylamine derivatives, useful as modulators of cortical and basal ganglia dopaminergic and N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic neurotransmission. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully